Market closed · Next open: Monday 9:30 AM ET
Last update: Jul 24, 2026, 6:18 PM ET
Hims & Hers Health, Inc.
$28.09 14.20% today
Market Closed

Why Hims & Hers Health, Inc. (HIMS) stock moved

Updated Jul 25, 2026

Hims & Hers Health, Inc. (HIMS) shares tumbled 14.2% to $28.09 as of July 25, 2026, a sharp decline from the prior close of $32.74. BestStocks flagged the session as a major change for HIMS. The move is tied to price move down. Below, we break down what changed for HIMS, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

HIMS fell 14.2% to $28.09

HIMS tumbled 14.2% in its latest session, moving from $32.74 to $28.09.

Material / EarningsMedium confidence
Rel. volume
1.5×
Normal
Vs peers
No comparable peers
Market cap
$6.3B
New York Stock Exchange
Analyst target
$30
+5.6% vs price
Price chart
Jun 24 – Jul 24
EEVVVVVFVVVFV$28$33$38Jun 24Jul 1Jul 10Jul 17Jul 24
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Hims & Hers Health, Inc. investors

For Hims & Hers Health, Inc. investors, the recent signals add up to a strong bearish shift. On the constructive side: Hims & Hers Health, Inc. (HIMS) moved +5.75% from $35.15 to $37.17 on 2026-07-15. Weighing against that: Material negative event; Sharp 14.2% decline — elevated risk. Wall Street's consensus price target sits at $29.67, implying +5.6% upside from $28.09. BestStocks rates the overall signal quality medium (62/100). With earnings roughly 16 days out, the next report is the most likely near-term test of the move.

HIMS price reaction

HIMS last traded at $28.09, down $4.65 (-14.20%) from the previous close of $32.74. The session traded on 1.5× average volume (normal), so participation was unremarkable. Over the past month the stock has ranged between $28.09 and $38.28, and it currently sits about 0% of the way up that band.

Bullish and bearish analyst opinions on Hims & Hers Health, Inc. (HIMS)

The consensus analyst price target on Hims & Hers Health, Inc. (HIMS) is $29.67, 5.6% above the recent $28.09. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 0 downgrades. Here is how the bullish and bearish cases on HIMS line up.

The bullish case

  • Wall Street's consensus price target of $29.67 implies +5.6% upside from $28.09.
  • The Street's most bullish target is $60.00 (+113.6%).
  • Hims & Hers Health, Inc. (HIMS) moved +5.75% from $35.15 to $37.17 on 2026-07-15.

The bearish case

  • The most bearish analyst target is $12.50 (-55.5%).
  • Material negative event.
  • Sharp 14.2% decline — elevated risk.
  • Hims & Hers Health, Inc. (HIMS) moved -9.39% from $37.17 to $33.68 on 2026-07-16.
Bull vs bear balanceStrong Bearish Shift
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is strongly bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 25, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $30+5.6%
= 13 maintains
Citigroup maintained Neutral · 2026-07-23
SEC filings watch
8-K2026-07-17
Material event — review for impact
high
8-K2026-07-01
Material event — review for impact
high
8-K2026-06-15
Material event — review for impact
high
8-K2026-06-02
Material event — review for impact
high
Peer context
HIMS-14.2%

Previous notable changes for HIMS

Material / Earnings2026-07-23+3.3%
Hims & Hers Health, Inc. (HIMS) moved +5.51% from $31.03 to $32.74 on 2026-07-23. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move was accompanied by volume 3.1x the 5-day average, suggesting institutional or algorithmic positioning ahead of the earnings announcement scheduled for 2026-08-10.
Activity2026-07-22-3.2%
Hims & Hers Health, Inc. (HIMS) moved −3.21% from $32.73 to $31.68 on 2026-07-22. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The decline coincided with HIMS reaching a new 30-day low; volume remained near its 5-day average.
Activity2026-07-20-0.4%
Hims & Hers Health, Inc. (HIMS) moved -0.43% from $32.84 to $32.70 on 2026-07-20. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. The move coincided with HIMS reaching a new 30-day low, with volume near its 5-day average.
Filings2026-07-17-2.5%
Hims & Hers Health, Inc. (HIMS) filed an 8-K on July 17, 2026. The audit contains only the filing notification itself; the specific content and purpose of the 8-K were not detailed in available evidence.
Upcoming catalysts & outlook
Next earnings
2026-08-10 (est.)
in 16 days
Thesis shift
Strong Bearish Shift
bearish signal
Risk level
High
from change events

Frequently asked questions about HIMS

Why did Hims & Hers Health, Inc. (HIMS) stock move?

HIMS tumbled 14.2% to $28.09. No single company-specific catalyst was confirmed during the move window, and it looks technical.

How much did HIMS stock fall?

HIMS lost 14.20% ($4.65) versus the prior close of $32.74, last trading at $28.09 on 1.5× average volume.

When is Hims & Hers Health, Inc.'s next earnings date?

HIMS's next earnings report is estimated for 2026-08-10 — about 16 days away.

What is the analyst price target for HIMS?

The consensus analyst price target for HIMS is $29.67, about 5.6% above the current $28.09. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 0 downgrades.

How BestStocks tracks HIMS

This page is generated automatically by BestStocks' change-detection system after price move down was detected and verified against independent data sources. It draws on 15 tracked change events for HIMS, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 25, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.